| bimatoprost / Generic mfg. |
NCT04285580: A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension |
|
|
| Completed | 3b | 37 | US | Bimatoprost SR, LUMIGAN | AbbVie | Open-Angle Glaucoma, Ocular Hypertension | 05/22 | 05/22 | | |
NCT02154217: Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures |
|
|
| Completed | 3 | 200 | Europe | Bimatoprost, Latanoprost/Timolol | University of Milan | Glaucoma | 12/04 | | | |
| Completed | 3 | 20 | US | Bimatoprost eyelash gel, lumigan | Duke University | Madarosis, Hypotrichosis | 09/07 | 12/08 | | |
NCT00693420: Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence |
|
|
| Completed | 3 | 278 | US, Canada | Bimatoprost 0.03% sterile solution, LUMIGAN®, vehicle sterile solution | Allergan | Eyelashes | 10/07 | 12/07 | | |
NCT00907426 / 2009-012304-55: Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin |
|
|
| Completed | 3 | 368 | US, Europe | Bimatoprost 0.03% solution, LATISSE™, Vehicle solution | Allergan | Hypotrichosis | 11/10 | 05/11 | | |
NCT01099774: Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension |
|
|
| Completed | 3 | 597 | US | Bimatoprost 0.03% Formulation B Ophthalmic Solution, Bimatoprost 0.03% Ophthalmic Solution, LUMIGAN® | Allergan | Glaucoma, Ocular Hypertension | 04/11 | 04/11 | | |
NCT01391273: Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis |
|
|
| Completed | 3 | 173 | Japan | bimatoprost solution 0.03%, LATISSE®, bimatoprost vehicle solution | Allergan | Eyelash Hypotrichosis | 05/12 | 05/12 | | |
NCT01391286: Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis |
|
|
| Completed | 3 | 36 | Japan | bimatoprost solution 0.03%, LATISSE®, bimatoprost vehicle solution | Allergan | Eyelash Hypotrichosis | 05/12 | 05/12 | | |
NCT01765764: Bimatoprost for the Treatment of Eyebrow Hypotrichosis |
|
|
| Completed | 3 | 357 | Canada, US | bimatoprost solution, Vehicle to bimatoprost solution | Allergan | Eyebrow Hypotrichosis | 01/14 | 02/14 | | |
| Completed | 3 | 464 | US, Europe, RoW | bimatoprost formulation A solution, bimatoprost solution 0.03 %, LATISSE®, vehicle of bimatoprost formulation A solution, vehicle of bimatoprost solution 0.03 % | Allergan | Idiopathic Eyelash Hypotrichosis | 02/14 | 03/14 | | |
NCT01830140: A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension |
|
|
| Completed | 3 | 466 | US | Bimatoprost 0.01%, LUMIGAN® 0.01%, Bimatoprost 0.03%, LUMIGAN® 0.03% | Allergan | Glaucoma, Ocular Hypertension | 05/14 | 05/14 | | |
| Terminated | 3 | 6 | US, Europe, RoW | bimatoprost ophthalmic solution formulation A, timolol ophthalmic solution, bimatoprost vehicle | Allergan | Glaucoma | 10/14 | 10/14 | | |
2014-002553-19: Bimatoprost 0,3mg/ml- Eyedrops for lash-lenghtening - Pilot Study Bimatoprost 0,3mg/ml- Augentropfen zur Wimpernverlänngerung - Pilotstudie, Halbseitenversuch |
|
|
| Completed | 3 | 15 | Europe | Eye drops, Lumigan 0,3 mg/ml | Medizinische Universität Graz, Universitätsklinik für Dermatologie, Medizinische Universität Graz | women with too short lashes Frauen mit zu kurzen Wimpern, too short lashes zu kurze Wimpern, Not possible to specify | | | | |
2010-020213-82: Comparison of Incidence and Severity of conjunctival hyperemia associated with use of topical Bimatoprost 0.01% and latanoprost 0.005% in Glaucoma or Ocular Hypertensive patients |
|
|
| Terminated | 3 | 30 | Europe | Eye drops, solution, lumigan 0.1, XALATAN | IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | glaucoma or ocular hypertension | | | | |
NCT02155049: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues |
|
|
| Completed | 3 | 10 | RoW | bimatoprost 0.03%, Lumigan (Allergan, Inc, Irvine, California) | Rabin Medical Center | Thyroid Associated Ophthalmopathies | 05/17 | 05/17 | | |
NCT03927443: A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension |
|
|
| Withdrawn | 3 | 0 | NA | SDP-133, Lumigan | Sun Pharmaceutical Industries Limited | Open Angle Glaucoma, Ocular Hypertension | 07/19 | 07/19 | | |
MERCURY 3, NCT03284853 / 2015-001528-41: Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension |
|
|
| Completed | 3 | 436 | Europe, RoW | Netarsudil/Latanoprost 0.02%/0.005%, GANFORT® | Aerie Pharmaceuticals | Open Angle Glaucoma, Ocular Hypertension | 11/20 | 11/20 | | |
|
| Completed | 3 | 485 | Europe | Bimatoprost, Lumigan® | Laboratoires Thea | Ocular Hypertension, Glaucoma | 02/21 | 02/21 | | |
NCT04890106: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma |
|
|
| Completed | 3 | 310 | US | Test - Bimatoprost 0.01% Ophthalmic Solution, Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) | Mankind Pharma Limited, CBCC Global Research | Glaucoma, Open-Angle | 08/22 | 08/22 | | |
NCT05401357: Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. |
|
|
| Recruiting | 3 | 168 | US | Test - Bimatoprost 0.01% Ophthalmic Solution, Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) | Amneal Pharmaceuticals, LLC, CBCC Global Research | Glaucoma, Open-Angle, Ocular Hypertension | 12/22 | 12/22 | | |
NCT05397600: Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients |
|
|
| Completed | 3 | 684 | Canada, US, RoW | Bimatoprost Ophthalmic | Laboratoires Thea | Glaucoma, Ocular Hypertension | 03/24 | 03/24 | | |
| Terminated | 3 | 28 | US | Latanoprost, Xalatan, Bimatoprost, Lumigan, Travoprost, Travatan, Timolol, Timoptic, Dorzolamide, Trusopt, Brinzolamide, Azopt, Acetazolamide, Diamox, Methazolamide, Neptazane | University of Miami, National Eye Institute (NEI) | Glaucoma | 10/24 | 10/24 | | |
NCT00300443: Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension |
|
|
| Completed | 2/3 | 561 | US | bimatoprost | Allergan | Ocular Hypertension | 06/07 | 06/07 | | |
| Completed | 2/3 | 18 | US | NCX 470, nitric oxide (NO)-donating bimatoprost prostaglandin analog, Placebo, Artificial tears | Nicox Ophthalmics, Inc. | Open Angle Glaucoma | 03/25 | 03/25 | | |
